aescolab
PrivateLast Round
Seed
Jun 3, 2025
Company Overview
aescolab is a healthtech company that provides high-quality blood biomarker analyses and personalized lifestyle recommendations to help individuals and employees improve their energy and well-being.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, D2C Brands, HR
Business Model
B2C
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
aescolab Comparables
Compare aescolab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HealthCaters | 80% | |
| Cerascreen | 79% | |
| Aniva Health | 78% | |
aescolab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 3, 2025 | ||||
| VC Round | Apr 6, 2025 | ||||
| Seed | Nov 1, 2024 |
Key People
Founding team and executive leadership
aescolab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KRING | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2026
Grew 36% QoQ, from 14 to 19 employees.
- Jan 23, 2026
Grew 36% QoQ, from 14 to 19 employees.
aescolab Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about aescolab's valuation, stock price, and market status.